Article Information
History
- September 13, 2021.
Article Versions
- You are currently viewing Version 1 of this article (September 13, 2021 - 11:03).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Jeroen H.A. Creemers1,2,
- Kit C.B. Roes3,
- Niven Mehra4,
- Carl G. Figdor1,2,
- I. Jolanda M. de Vries1 and
- Johannes Textor1,5,*
- 1Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Nijmegen, The Netherlands
- 2Oncode Institute, Nijmegen, The Netherlands
- 3Department of Health Evidence, Section Biostatistics, Radboudumc, Nijmegen, The Netherlands
- 4Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands
- 5Data Science Department, Institute for Computing and Information Sciences, Radboud University, Nijmegen, The Netherlands
- ↵*Corresponding author: Dr. J. Textor, Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboudumc, Geert Grooteplein 26, 6500 HB Nijmegen (P.O. Box 9101), The Netherlands, E-mail: johannes.textor{at}radboudumc.nl, Phone: 0031-24 361 76 00